ERBB4 loss is most frequently found in invasive breast carcinoma and prostate adenocarcinoma, while ERBB2 loss is found in ovarian high-grade serous carcinoma and invasive breast carcinoma. This evidence concerns the gene ERBB2 and invasive breast carcinoma.